- Home
- AR vs BAX Comparison
AR vs BAX Comparison
Compare AR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AR | BAX |
|---|---|---|
| Founded | 2002 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 10.2B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | AR | BAX |
|---|---|---|
| Price | $38.75 | $17.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 9 |
| Target Price | ★ $44.63 | $22.38 |
| AVG Volume (30 Days) | 5.3M | ★ 9.4M |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | ★ 1027.78 | N/A |
| EPS | ★ 2.03 | N/A |
| Revenue | $5,275,823,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $23.61 | $1.90 |
| Revenue Next Year | $6.22 | $2.09 |
| P/E Ratio | $19.08 | ★ N/A |
| Revenue Growth | ★ 21.97 | 5.72 |
| 52 Week Low | $29.10 | $17.40 |
| 52 Week High | $44.02 | $36.57 |
Technical Indicators
Market Signals| Indicator | AR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 67.53 | 34.45 |
| Support Level | $32.27 | $17.69 |
| Resistance Level | $40.42 | $19.31 |
| Average True Range (ATR) | 1.30 | 0.78 |
| MACD | 0.43 | -0.38 |
| Stochastic Oscillator | 82.10 | 16.75 |
Price Performance
Historical ComparisonAbout AR Antero Resources Corporation
Antero Resources, based in Denver, explores for and produces natural gas and natural gas liquids in the United States and Canada. At the end of 2025, the company reported proven reserves of 19.1 trillion cubic feet of natural gas equivalent. Production averaged approximately 3,442 million cubic feet of equivalent per day in 2025 at a ratio of 35% liquids and 65% natural gas.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.